Blog

Psilocybin’s Effects on the Auditory Cortex in Mice

Jul 10 • 4 min read

Recent research has uncovered significant insights into how psilocybin impacts the auditory cortex in mouse models. Psilocybin, a natural psychedelic compound found in over 200 species of fungi, is renowned for inducing altered states of consciousness, including shifts in cognition, mood, and perception. Various studies have explored psilocybin’s potential in treating mental health disorders such…

Cybin Inc. Stands Strong As A Remaining Force To Prove Benefits Of Psychedelic Therapeutics ($CYBN)

Jul 10 • 8 min read

Cybin Inc., a breakthrough therapy company (NYSE: CYBN) (CBOE CA: CYBN) continues to show that its microcap share price may not be a fair reflection of a company that is helping usher in a transformation in how many mental health conditions are treated. And its method is certainly not more of the same-far from it….

Optimind Pharma Closes First Tranche of Private Placement

Jul 9 • 1 min read

Toronto, Ontario–(Newsfile Corp. – July 8, 2024) – Optimind Pharma Corp. (CSE: OMND) (“Optimind” or the “Company”) announces it has closed the first trance of its previously announced private placement. The Company issued 2,900,000 common shares at a price of $0.05 per share to investors for gross proceeds of $145,000. The Company expects to close…

Red Light Holland CTIO to Unveil Groundbreaking iMicroapp Research Findings to Prestigious Drug Science Consortium

Jul 9 • 3 min read

Toronto, Ontario–(Newsfile Corp. – July 9, 2024) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) (“Red Light Holland” or the “Company”), a company engaged in the production, growth and sale of functional mushrooms and mushroom home grow kits in North America and Europe and a premium brand of psilocybin truffles to the…

Mindbio Therapeutics CEO Issues Letter To Shareholders

Jul 9 • 8 min read

VANCOUVER, BC / ACCESSWIRE / July 8, 2024 / MindBio Therapeutics Corp. (CSE:MBIO)(Frankfurt:WF6), (the “Company” or “MindBio”), a leading biopharmaceutical company in psychiatric medicine development today issued a letter to shareholders from Justin Hanka, Co-Founder and Chief Executive Officer of MindBio. Dear Shareholders, We are delighted to provide an update on progress at MindBio, as we head…

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538